CallTower Wins Five9 Global Partner Rising Star Award
CallTower is recognized for enabling and delivering success in helping organizations reimagine their customer
Globe Newswire1-02-2023, 15:09
Survodutide Phase II trial shows 83% of adults treated achieved groundbreaking results in liver disease due to MASH, with significant improvements in fibrosis 26-02-2024, 14:05